Our findings shed new light on the critical role of the IFNβ-JAK1/TYK2-STAT1-IRF7 pathway in MRP8/14-induced IP-10 expression in the progression of endotoxemia, which may provide new therapeutic strategies for sepsis. Here, S100A8 is linked to serum lipopolysaccharide activity.